Khiron Signs LOI to Acquire the Latin American Institute of Neurology and the Nervous System | CashCropToday
0 Shares 786 Views

Khiron Signs LOI to Acquire the Latin American Institute of Neurology and the Nervous System

August 8, 2018
786 Views

Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian public cannabis company that operates out of Colombia, has announced this week that it has entered into a LOI with the Latin American Institute of Neurology and the Nervous System (ILANS) to acquire the company under its wholly owned subsidiary Khiron Colombia SAS.

ILANS has been growing into one of the largest health service provider networks in Latin America. The two companies have recently entered into a strategic alliance where Khiron would supply medicinal cannabis to patients in need at ILANS facilities in South America.

If the transaction is successful, Khiron will be acquiring two neurological clinics located in Bogota, an estimate network of over 100,000 patients and 46 physicians to their medical team. ILANS has generated a reported revenue of $10.5M in 2017.

Khiron will be purchasing the Latin American Institute of Neurology and the Nervous System for $7.0 million dollars, 70% of which will be delivered in cash and 30% will be delivered in stock.

“This acquisition represents one of the most significant developments for Khiron to date. We will secure a significant revenue stream from patients within our target market and see multiple opportunities to further scale revenue and drive profitability from introducing medical cannabis to ILANS patients,” said Alvaro Torres, CEO of Khiron.

You may be interested

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX
Market Watch
9 views
Market Watch
9 views

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX

Jaelynn Offerman - October 22, 2018

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages
Global
7 views
Global
7 views

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages

Jaelynn Offerman - October 22, 2018

Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…

MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5M
Market Watch
41 views
Market Watch
41 views

MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5M

Editor - October 19, 2018

MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) announced this week that the company has agreed to sell three seperate cannabis retail locations to Treehouse Real Estate Investment…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: